ArticleCase reports in oncology

Rechallenging Unresectable Hepatocellular Carcinoma with the STRIDE Regimen: A Case Report of Significant AFP Response after Atezolizumab-Bevacizumab Intolerance.

Sugat Adhikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.